Evidence map›Paper›PMID 40177570›Full record

ArticleActa pharmaceutica Sinica. B2025

Locally producing antibacterial peptide to deplete intratumoral pathogen for preventing metastatic breast cancer.

Shizhen Geng, Tingting Xiang, Yaru Shi, Mengnian Cao, Danyu Wang, Jing Wang, Xinling Li, Haiwei Song, Zhenzhong Zhang, Jinjin Shi and 3 more

Abstract read
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. The Role of Selected Bacteria in Breast Cancer Initiation and Development.International journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. MedComm · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shizhen GengDepartment of Urinary Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Tingting XiangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Yaru ShiSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Mengnian CaoSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Danyu WangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Jing WangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Xinling LiSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Haiwei SongSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Zhenzhong ZhangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Jinjin ShiSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Junjie LiuSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Airong LiSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Ke SunDepartment of Urinary Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastatic dissemination is the major cause of death from breast-cancer (BC).

Indexed as

Antibacterial peptideBreast cancerCancer-associated fibroblastFusobacterium nucleatumIntratumoral pathogenMetastasisMild heatOptogenetics

Identifiers

PMID40177570
PMCPMC11959924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.